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1 Introduction
The dominant business model in scientific publishing is ‘reader pays’, i.e., university libraries pay
for academic journals through subscriptions. However, an alternative model is gaining momentum
where authors pay and readers have free and immediate access (‘open access’) to the full text of
scientific articles. The emergence of open access is facilitated by sharp decreases in dissemination
costs with the advent of electronic publishing, growing expectations that the results of publicly
funded research should be freely available and increased strains on library budgets associated with
substantial increases in journal prices (McCabe 2002, Dewatripont et al. 2006).
A large number of open access journals have been created- the directory of open access journals
currently lists more than 3000 entries. Separately, publishers are increasingly offering authors the
possibility to buy open access to their articles in subscription-based journals. Initially pioneered
by a number of not-for-profit publishers, open access options are now offered by almost all major
publishers1.
Despite concerns that open access journals may be of lower quality (Jeon & Rochet 2007, McCabe
& Snyder 2006), some have established themselves as prestigious outlets. For instance, the open
access journal PLoS Pathogens has an impact factor above nine and is the leading journal in the
field of parasitology.
An important question in this context is whether (and by how much) open access increases
the number of citations received by scientific papers. As researchers care about the visibility of
their work, they may be willing to pay to ensure that their work receives a larger number of
citations. Indeed the present value of a single additional citation for a 35-year-old physicist’s work
was estimated to exceed 3000 current dollars (Diamond 1986). Because the open access citation
advantage underpins the willingness of authors and institutional actors to pay for open access, it is
central to the dynamics of the scientific publishing market.
The mainstream opinion in the information science literature is that open access increases the
number of citations received by scientific papers and that this effect is quantitatively important.
The seminal contribution is Lawrence (2001) who finds that computer science conference articles
that were openly accessible on the Web were cited more often than those that were not (+150%).
Studies by Walker (2004) and Antelman (2004) also find an open access citation advantage by
1The Entomological Society of America and the American Society of Limnology and Oceanography were among
the first to sell open access by the article, beginning in 2001 (Walker 2004). The Company of Biologists offers an open
access option in its journals Development, Journal of Cell Science, Journal of Experimental Biology since January
2004. Proceedings of the National Academy of Science started to offer an open access option in May 2004. The
major publishers have followed, although not for all their journals: Elsevier (‘Sponsored articles’) Springer(‘Open
Choice’) Blackwell (‘Online Open’) Taylor & Francis (‘iOpen Access’), John Wiley & Sons (‘Funded Access’) Oxford
University Press (‘Oxford open’).
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comparing sample means of citations2. The most influential of these studies is Eysenbach (2006)
who compares the citation rates between open access and non-open access articles published in the
second half of 2004 in Proceedings of the National Academy of Sciences (PNAS). Controlling for
number of authors, authors’ lifetime publication count and impact, submission track, country of
corresponding author, funding organization, and discipline, he finds that open access articles were
twice more likely to be cited in the first 4-10 months after publication.
This view has been challenged by Davis et al. (2008) who randomly allocated papers from
journals of the American Physiological Society into open access and found no open access citation
advantage after one year. In the appendix, we report similar results for an experiment undertaken
by the Journal of Medical Genetics. While these results suggest that there might be no effect at all,
they do not quite settle the debate. In particular, they do not provide a convincing explanation of
the mechanism generating the open access advantage observed in the earlier studies. To the extent
that the effect of open access is heterogeneous across journals, it could be that there is no effect in
the journals where the experiments were undertaken but that there is an effect in other journals.
In this paper, we first show explicitly in a simple model why comparisons of means might lead to
upward biased estimates of open access. A larger readership is especially valuable if the paper is of
high quality: for a given increase in the number of readers, a higher quality paper will receive more
additional citations than a lower quality paper. Thus, open access is relatively more attractive to
authors of high quality papers and thus open access papers tend to be of higher quality on average.
Consequently, regressions of the number of citations on open access capture both a diffusion effect
and a self-selection effect.
Empirically, we analyze a sample of 4388 biology papers published between May 2004 and
March 2006 by Proceedings of the National Academy of Sciences (PNAS) an important, high-
volume scientific journal which started to offer an open access option to authors in May 2004 for
a USD 1000 fee. We find empirical evidence of self-selection using an original measure of article
quality, i.e. the ratings from F1000 biology, a website where biology professors evaluate new papers
of interest. We also implement an instrumental variable strategy where our preferred instrument
is a dummy for publication of the article in the last quarter of the fiscal year. The idea here is
that academic departments may have unused budgets that must be spent before the end of the
fiscal year (or the funds are lost). Thus, discretionary spending on otherwise low-priority items
such as paying for optional open access fees is more likely to be observed towards the end of the
year, which is born out by our data. Using this instrument, we find that the coefficient of open
access is insignificant and reduced compared to the coefficient of a simple ordinary least squares
regression. Similar results are found with other instruments (and combinations thereof): a change
2Walker (2004) reports that articles published by the American Society of Limnology and Oceanography with open
access in 2003 were downloaded more often (+180%) than online articles accessible only to subscribers. Antelman
(2004) finds that freely available articles were more frequently cited than those in restricted in electric engineering
(+51%), mathematics (+91%), philosophy (+45%) and political science (+86%).
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of publication policy for NIH intramural researchers and a dummy for Howard Hughes Medical
Institute investigators (who receive a special budget to pay open access fees).
Our results are consistent with the self-selection of higher quality article into open access.
Although a diffusion effect of open access cannot be ruled out, our results suggest that it is smaller
than previously thought, if it exists at all.
The rest of the article is organized as follows. Section 2 introduces a simple model of the open
open access choice. Section 3 describes the data used in this paper. The econometric specification
and results are presented in section 4. Section 5 concludes.
2 A simple model
We formalize here the idea that open access is relatively more attractive to authors of higher quality
papers and its implications. Let qi be the quality of the article defined as the probability of the article
being cited conditional on the article being read. qi is exogeneously given and heterogenous across
articles. The number of citations N generated by an article of quality qi is thus N(qi, n) = nqi where
n is the number of readers. Authors value citations as they help them secure peer recognition, jobs,
promotions and continued research funding (Stephan 1996). However, the present value of a citation
may vary across authors for instance according to age and career stage. δj is the (heterogeneous
and exogeneously given) present value of a citation.
Authors maximise the present value of the number of citations generated by an article minus
the publication cost c:
UA = δjnqi − c (1)
Authors can choose to publish in open access (OA) or in restricted access (RA). The publication
cost for the author is cOA if he publishes in open access and zero otherwise. The number of
readers is nOA if the article is published in open access and nRA otherwise, with nOA ≥ nRA.
Utility maximisation thus involves resolving a tradeoff between the costs of publication and a larger
readership. An author will choose to publish in open access if
(nOA − nRA)δjqi ≥ cOA (2)
The comparative statics are straightforward: a paper is more likely to be published in open
access if the quality qi of the paper is high, if the present value of a citation δj is high, if the cost of
publishing cOA in open access is low and if the increase in readership associated with open access
(nOA − nRA) is high.
The fact that a paper is more likely to be published in open access if the quality of the paper is
high has important implications empirically. What we really would like to know is the percentage
increase in the number of citations for an article of a given quality. However, what we observe is the
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percentage difference of citations between open access papers and restricted access papers. Since
being in open access is not randomly assigned but is the outcome of a maximization process, the
observed difference in citations is upward biased.
3 Data
3.1 The PNAS dataset
We use data from a single journal which enables us to have a more homogeneous sample and to
focus on within-journal variability. Our original dataset consists of 4388 articles published in the
scientific journal Proceedings of the National Academy of Sciences (PNAS) between May 2004 and
March 2006. PNAS is an important scientific journal which is second only to Nature and Science
in reputation and impact factor within the multidisciplinary science journals. It publishes a high
volume of primary research papers (weekly issues with 60 papers per issue).
Upon acceptance of their papers, PNAS authors are offered the possibility to buy open access
exchange for a USD 1000 fee. If they pay the fee, the electronic version of the paper is available for
free on the journal website. If they choose not to buy open access, access is restricted to subscribers
for the first six months. In any case, readers based in developing countries have free and immediate
access to all articles.
We focus on articles published in the area of biological sciences which represents approximatively
90% of papers published in PNAS. An important point is that contrary to economics or physics,
circulation of pre-publication papers (working papers, preprints,...) is inexistent in biology where
pre-publication would significantly decrease the chances of subsequent publication in an academic
journal. Self-archiving by authors is also uncommon. To verify that, we searched for full text
versions of articles published in one issue of PNAS three months after its publication. Of the 43
articles published in restricted access, we were able to find only two cases where a full-text version
was freely available elsewhere on the web.
For cited papers, we know from the website of the journal whether the article was published
in open access or not, the names of the authors, the publication date, the subfield in which it was
published, the email address of the corresponding author, the submission track3 and whether the
article was featured on the cover of the journal.
3.2 Citation data
Citation data were extracted from ISI Web of Science which includes citations from over 7000
scientific journals. For citing papers, we know the time of publication and the journal where they
3In additional to the usual submission track where authors submit manuscripts to the editorial office, this journal
has two special submission tracks. Academy members can submit their own papers with two referee reports to the
editorial office (track III). They can also communicate manuscripts from other authors that they find interesting
(track I).
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are published. We use this information to construct the cumulative number of citations after various
lengths of time.
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Figure 1: Mean total number of citations for open access articles (dotted line) with 95 percent
confidence interval (light gray) and restricted articles access articles (solid line) accumulated
after various time intervals. The sample is all research articles published in Proceedings of
the National Academy of Sciences between May 2004 and March 2006 (5498 papers).
Figure 1 displays the mean and 95% confidence intervals of citations accumulated over time for
both open access and restricted access papers. About 17% of our sample consists of open access
papers. A citation advantage of open access article is apparent from the raw data. For the rest
of the paper we focus on the number of citations accumulated within two years as our dependent
variable as this is where we have most variability.
3.3 Controls
Author quality. We construct two proxies to control for author quality. First, we match the
names of the last author (who is typically the head of the lab) with Medline data extracted using
PublicationHarvester (Azoulay et al., 2006). We use these data to construct the variable ’Last
author productivity’ which is defined as the number of publications of the last author weighted by
the impact factor of the publishing journal and divided by the number of years since (s)he started
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publishing4. Second, we construct a dummy that takes value 1 if the last author is a superstar,
i.e. if (s)he is appears on one of ISI Web of Science lists of 250 most cited researchers in various
subfields of biology.
Article quality. We use a novel proxy for article quality which is the evaluation given by biology
professors on the website F1000 Biology5. Contributors to this website post short summaries of
recently published papers together with an evaluation which can be either ’recommended’, ’must
read’ or ’exceptional’. The contributors are all university professors and experts in particular
subfields of biology. Around 19% of articles in our sample have received an evaluation on F1000:
12% appear as ’recommended’, 6% as ’must read’ and 1% as ’exceptional’.
Since open access might be motivated by a desire to facilitate access to readers outside the
scientific community, we also construct a dummy ’Broad appeal’ that takes value 1 if the article
was cited in Scientific American, New Scientist, the Economist or the French mainstream press.
Table 1 - Descriptive Statistics
Variable: Obs Mean Std. Dev. Min Max
Dependent variable (Y):
Citations after two years 4388 13.06 11.62 0 171
Control variables (X):
Last author productivity 4388 0.27 0.34 0 3.13
Number of authors 4388 5.77 3.48 1 60
Years since 1st publication 4388 24.31 10.36 0 36
Open access 4388 0.17 - 0 1
F1000 = ”recommended” 4388 0.12 - 0 1
F1000 = ”must read” 4388 0.06 - 0 1
F1000 = ”exceptional” 4388 0.01 - 0 1
Broad appeal 4388 0.02 - 0 1
Superstar 4388 0.12 - 0 1
From the cover 4388 0.08 - 0 1
Submission = Track II (standard submission) 4388 0.48 - 0 1
Submission = Track III (academy members) 4388 0.28 - 0 1
Private firms 4388 0.03 - 0 1
National Institutes of Health (NIH) 4388 0.04 - 0 1
Instruments (Z):
NIH - post reform 4388 0.02 - 0 1
End of fiscal year 4388 0.17 - 0 1
Howard Hughes Medical Institute (HHMI) 4388 0.06 - 0 1
4One problem we encountered is that it is difficult to identify publications for authors with common last names.
The procedure we used to deal with this issue was to exclude observations where the last author had a very common
last name (more than 5 occurrences of different authors with the same last name in our dataset). This results in a
loss of 590 observations mainly for papers with last authors with an Asian name. For moderately common names
(between 2 and 5 occurrences of different authors with the same last name in our dataset), we kept them in the
dataset but adjusted the total number of publications downwards by dividing the total number by the number of
different occurrences in the dataset. The results of our paper are robust to alternative specifications.
5http://www.f1000biology.com
7
3.4 Instruments
Our empirical strategy consists of instrumenting open access to isolate the effect of diffusion from
self-selection. Our preferred instrument is a dummy for publication in the last quarter of the fiscal
year. We exploit here the fact that academic departments may have leftover budgets that need to
be spent before the end of the fiscal year6. One otherwise low-priority item on which budgets can
be spent is paying for open access fees for papers about to be published in PNAS. While there is
evidence of fiscal year seasonality influencing economic outcomes (Oyer 1998), to the best of our
knowledge we are the first to use it as an instrument. In our data, 21% of articles published in the
last quarter of the fiscal year are in open access compared to 15% for the three other quarters. At
Harvard, where the fiscal year ends on the 30th of June, 42% of articles published in April, May
and June are in open access compared to 15% for those published in the rest of the year. The
interest of this instrument is not so much its strength but the high likelihood that it is exogeneous
since we expect that the timing of publication within the year to have no relationship with article
quality.
Our second instrument is a dummy that takes value 1 if the corresponding author is an intramural
researcher of the National Institutes of Health (NIH) and the article was published after April 2005.
The NIH issued a new policy on open access in February 2005, to be implemented in May 2005.
Although this policy was primarily aimed at research funded by the NIH and conducted extra
muros, it also had an effect on NIH intramural researchers. Before the change in policy, only 13%
of articles authored by NIH intramural researchers were in open access. After the change in policy,
the corresponding number was 28%. Since we control for being an NIH intramural researcher and
for time trends, we expect the instrument to capture only the effect of open access. Our third
instrument is a dummy that takes the value 1 if one of the authors is an investigator for the
Howard Hughes Medical Institute (HHMI). The HHMI provides a special budget of USD 3000 to
its investigators to pay for open access fees. Since HHMI investigatorships are prestigious, it is
important that we control for author quality to ensure the validity of the instrument.
4 Econometric specification and results
As a benchmark we estimate with ordinary least squares and robust standard errors:
Y = δ ∗ open access+Xβ + ε (3)
where Y is the number of citations after two years and X is the complete set of control variables
described in the preceding section.
6We coded the end of the fiscal year as follows: end of June for US-based academic institutions; end of September
for US government, end of December for other countries.
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We then implement the instrumental variable strategy with two-stage least squares (2SLS) and
with GMM which is more efficient 2SLS under conditional heteroskedasticity (Hayashi 2000). We
refrain from using a nonlinear first stage such as a probit or logit, because the second stage estimates
would not be consistent if the functional form of the first stage was incorrect (Angrist 2001, Angrist
& Krueger 2001).
The results of the benchmark OLS regression are reported in the first column in table 1. The
coefficient on open access is positive and significant at the 1% confidence level. The coefficient
is robust to various combinations of controls. It is also quantitatively important with 4.091 more
citations for open access articles than restricted access articles (95% confidence interval: [2.95;
5.22]). These results are in line with those of Eysenbach (2006) who concluded that open access
facilitates the dissemination of research findings.
The first stage of the two-stage least squares regression with the three instruments is displayed in
column II. The three instruments are significant at the 1% confidence level. The first stage provides
evidence of self-selection of higher quality articles into open access. The coefficient on our proxies
for article quality (the evaluation on F1000 biology and broad appeal) are positive and significant.
The dummy for ’must read’ is significant at the 5% confidence level. The dummy for ’exceptional’
is not significant but the number of articles in this category is very small. A joint F-test on the
three F1000 dummies reject the null that they are not different from zero at the 1% confidence
level. As robustness check, we ran a probit of open access on the same explanatory variables with
the same results.
The second stage of the two-stage least squares is displayed in column III and the results of
the GMM estimation in column VI. When we instrument, the coefficient on open access decreases
considerably and is and no longer significant. As robustness check we run two stage least squares
with different combinations of the instrument and find coefficients for open access taking values
between -2.978 and 2.309 (cf. appendix).
A number of other arguments further suggest that the open access advantage observed in the
raw data (figure 1) and in the non-instrumented specification (column 1) does not come from a
diffusion effect of open access. In particular, PNAS papers are freely accessible to developing
countries from the date of publication and PNAS is one of the least expensive scientific journals
in terms of both price per article and price per citation. Open access articles enjoy an even larger
citation advantage considering citations in Science, Nature and Cell, although authors publishing
in these highly prestigious journals can hardly be expected to lack extensive access to the scientific
literature. We report the details of these results elsewhere (cf. Gaule & Maystre 2008).
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Table 2 - Results
Pooled 2SLS 2SLS GMM
OLS 1ststage 2ndstage
(I) (II) (III) (IV)
Two years Open Two years Two years
citations access citations citations
Open access 4.091a 0.857 0.423
[0.579] [4.482] [4.401]
F1000 = ”recommended” 3.445a 0.02 3.528a 3.573a
[0.628] [0.017] [0.657] [0.651]
F1000 = ”must read” 4.933a 0.054b 5.114a 5.161a
[0.814] [0.026] [0.657] [0.651]
F1000 = ”exceptional” 6.578b 0.064 6.812a 6.753a
[2.642] [0.084] [2.536] [2.564]
Broad appeal 2.847c 0.147a 3.309c 3.396c
[1.591] [0.044] [1.763] [1.755]
Superstar 3.041a 0.011 3.075a 3.126a
[0.782] [0.020] [0.791] [0.786]
From the cover 6.150a -0.002 6.141a 6.118a
[0.877] [0.022] [0.879] [0.870]
Last author productivity 2.730a 0.001 2.769a 2.744a
[0.789] [0.021] [0.785] [0.783]
Submission = Track II -0.137 -0.089a -0.421 -0.453
[0.405] [0.014] [0.561] [0.557]
Submission = Track III -1.342a -0.042b -1.458a -1.461a
[0.493] [0.017] [0.512] [0.512]
Number of authors 0.615a -0.023a 0.541a 0.532a
[0.083] [0.002] [0.127] [0.126]
Years since 1st publication -0.068a -0.001 -0.071a -0.071a
[0.018] [0.001] [0.018] [0.018]
Private firms 0.924 0.220a 1.643 1.742
[1.003] [0.040] [1.423] [1.410]
N.I.H. -0.676 -0.059c -0.556 -0.487
[0.753] [0.033] [0.750] [0.737]
End of fiscal year 0.050a
[0.016]
NIH - post reform 0.180a
[0.055]
H.H.M.I. 0.109a
[0.027]
Year FE yes yes yes yes
Subfield FE yes yes yes yes
Constant 7.825a 0.267a 8.733a 8.850a
(Biochemistry subfield) [0.825] [0.025] [1.469] [1.451]
F test on IVs 12.13
Hansen J stat. / P-value 0.28 / 0.87
Observations 4388 4388 4388 4388
R-squared 0.13 0.09
Notes: Robust standard errors in brackets. c significant at 10%; b at 5%; a at 1%
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5 Concluding remarks
The specific contribution of this paper is to show (1) at least part of the larger number of citations
received by open access papers is due to a self-selection effect rather than a diffusion effect and
(2) that the diffusion effect of open access is smaller than previously thought. While the evidence
presented in this paper is not favorable to a large effect of open access on citations, a small effect
cannot be ruled out.
One puzzle is that in the absence of a citation advantage, we should not observe open access in
equilibrium in our model. This inconsistency is more apparent than real however. If authors (or
even a fraction of authors) believe that open access increases the number of citations, some of them
will choose open access and self-selection dynamics will occur. While this belief is not rational in
the simple setup of the model, it is consistent with the information set that authors had when they
made the decision to buy open access- that open access increases the number of citations was a
commonly held view.
An important limitation of studies based on citations is that they do not capture ’invisible
readers’ i.e. readers that do not themselves publish in scientific journals. Although the main
readership of scientific papers is scientists themselves, students and practitioners occasionally read
scientific articles, in particular in medicine.
It is also important to keep in mind that even if open access does not have any diffusion effect,
it might be welfare-enhancing for other reasons. For instance, it might save readers time by making
access to the full text more convenient and avoiding the need to navigate a complicated web of
digital rights management restrictions. Open access may facilitate indexing and referencing by
robots (such as Google indexing) which makes scientific information easier to find. Moreover, open
access may have a procompetitive effect in the scientific publishing market where anticompetitive
concerns have repeatedly been voiced (Bergstrom 2001, Wellcome Trust 2003, Dewatripont et al.
2006). The successful launch of the Public Library of Science and its open access journals PLOS
Medicine and PLOS Biology in 2006 was followed by profitability warnings regarding Elsevier and
other important publishers.
A final thought is that it is perhaps not surprising that open access does not appear to have an
important effect on citations. In a world of open science full disclosure of results is a central norm
(David 2003). One manifestation of the norm is that authors are almost always willing to send
electronic copies of their papers to anyone who requests them. Our advice to authors is to abide by
that norm and to use the 1000-3000 dollars open access publication fee for something else, unless
they have time-limited budgets to use!
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A Appendix: the Journal of Medical Genetics experiment
In 2005 and 2006, the Journal of Medical Genetics did an experiment whereby papers from UK
authors were randomized into open access and closed access (Maher 2005). Specifically, ”a ran-
domisation table was constructed by an independent statistician and is administered by the journal
editorial assistant...” (Folkes personal communication 2008). We identified the research papers pub-
lished in open access under this scheme (19 papers) and papers which would have been eligible but
were published in restricted access (104 papers) and compared their citation rates and extracted
all citations to papers from both groups. It turns out that the mean number of citations for open
access papers is no larger than for restricted access papers (cf. figure 2).
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Figure 2: Mean number of citations for open access articles (dotted line with 95 percent
confidence interval in light grey) and restricted access articles (solid line with 95 percent
confidence in dark grey) are represented after various length of time. The confidence interval
is obtained by regressing the cumulative number of citations on open access using robust
standard errors. The sample is all papers published in Journal of Medical Genetics (JMG)
by UK-based authors between January 2005 and December 2006.
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B Robustness checks
Table 3 - Robustness check: one instrument only
2SLS 2SLS 2SLS 2SLS 2SLS 2SLS
1ststage 2ndstage 1ststage 2ndstage 1ststage 2ndstage
(I) (II) (III) (IV) (V) (VI)
Open Two years Open Two years Open Two years
access citations access citations access citations
Open access 2.309 -2.978 1.912
[9.894] [7.913] [6.471]
F1000 = ”recommended” 0.026 3.490a 0.025 3.626a 3.501a
[0.017] [0.702] [0.017] [0.672] [0.017] [0.669]
F1000 = ”must read” 0.056b 5.033a 0.057b 5.329a 0.053b 5.055a
[0.026] [1.004] [0.026] [0.939] [0.026] [0.903]
F1000 = ”exceptional” 0.071 6.707b 0.072 7.088a 0.066 6.736a
[0.087] [2.627] [0.086] [2.564] [0.083] [2.570]
Broad appeal 0.144a 3.101 0.143a 3.857c 0.145a 3.158c
[0.044] [2.132] [0.044] [2.009] [0.044] [1.904]
Superstar 0.011 3.060a 0.009 3.116a 0.012 3.064a
[0.021] [0.796] [0.020] [0.800] [0.020] [0.793]
From the cover -0.003 6.145a -0.002 6.129a -0.003 6.144a
[0.022] [0.880] [0.022] [0.892] [0.022] [0.876]
Last author productivity 0.013 2.751a 0.013 2.815a -0.001 2.756a
[0.013] [2.751] [0.013] [2.815a] [-0.001] [2.756a]
Submission = Track II -0.089a -0.293 -0.088a -0.758 -0.088a -0.328
[0.014] [0.960] [0.014] [0.815] [0.014] [0.687]
Submission = Track III -0.034b -1.406b -0.036b -1.596a -0.043b -1.420a
[0.017] [0.588] [0.017] [0.585] [0.017] [0.537]
Number of authors -0.023a 0.574b -0.023a 0.453b -0.023a 0.565a
[0.002] [0.239] [0.002] [0.196] [0.002] [0.166]
Years since 1st publication -0.001 -0.069 -0.001 -0.074a -0.001 -0.070a
[0.001] [0.020] [0.001] [0.020] [0.001] [0.019]
Private firms 0.218a 1.32 0.222a 2.496 0.225a 1.408
[0.040] [2.429] [ 0.040] [2.046[] [0.040] [1.753]
N.I.H. 0.037 -0.61 -0.065b -0.414 0.043 -0.595
[0.030] [0.845] [0.033] [0.761] [0.030] [0.772]
End of fiscal year 0.048a
[0.016]
NIH - post reform 0.181a
[0.055]
H.H.M.I. 0.106a
[0.028]
Year FE yes yes yes yes yes yes
Subfield FE yes yes yes yes yes yes
Constant 0.273a 8.326a 0.285a 9.810a 0.271a 8.437
(Biochemistry subfield) [0.025] [2.874] [0.025] [2.355] [0.025] [1.967]
F test on IVs 9.377 10.746 14.82
Observations 4388 4388 4388 4388 4388 4388
R-squared 0.09 0.09 0.09
Notes: Robust standard errors in brackets. c significant at 10%; b significant at 5%; a significant at 1%
15
